Campylobacter jejuni Biofilm Assessment by NanoLuc Luciferase Assay
Campylobacter jejuni, a widespread pathogen found in birds and mammals, poses a significant risk for zoonosis worldwide despite its susceptibility to environmental and food-processing stressors.
Tjaša Čukajne +5 more
doaj +6 more sources
Coelenterazine analogues emit red-shifted bioluminescence with NanoLuc [PDF]
Synthesis and biological investigation of coelenterazine analogs that demonstrate a tunable red-shift in their bioluminescent emission with NanoLuc luciferase.
Anton Shakhmin +5 more
core +9 more sources
Transgenic luciferase-expressing Plasmodium falciparum parasites have been widely used for the evaluation of anti-malarial compounds. Here, to screen for anti-malarial drugs effective against multiple stages of the parasite, we generate a P.
Yukiko Miyazaki +11 more
doaj +2 more sources
Illuminating the mechanism and allosteric behavior of NanoLuc luciferase
Abstract NanoLuc, a superior β-barrel fold luciferase, was engineered 10 years ago but the nature of its catalysis remains puzzling. Here experimental and computational techniques were combined, revealing that imidazopyrazinone luciferins bind to an intra-barrel catalytic site but also to an allosteric site shaped on ...
Michal Nemergut +17 more
core +6 more sources
Mechanical Stability of a Small, Highly-Luminescent Engineered Protein NanoLuc [PDF]
NanoLuc is a bioluminescent protein recently engineered for applications in molecular imaging and cellular reporter assays. Compared to other bioluminescent proteins used for these applications, like Firefly Luciferase and Renilla Luciferase, it is ~150 times brighter, more thermally stable, and smaller. Yet, no information is known with regards to its
Yue Ding +2 more
openaire +3 more sources
Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays. [PDF]
The protozoan parasite Leishmania causes leishmaniasis; a spectrum of diseases of which there are an estimated 1 million new cases each year. Current treatments are toxic, expensive, difficult to administer, and resistance to them is emerging.
Sarah L Berry +6 more
doaj +3 more sources
Holistic monitoring of Campylobacter jejuni biofilms with NanoLuc bioluminescence
Campylobacter jejuni, a major cause of foodborne zoonotic infections worldwide, shows a paradoxical ability to survive despite its susceptibility to environmental and food-processing stressors. This resilience is likely due to the bacterium entering a viable but non-culturable state, often within biofilms, or even initiating biofilm formation as a ...
Tjaša Čukajne +5 more
openaire +5 more sources
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms [PDF]
tag-Targeted Protein Degrader (tTPD) systems are powerful tools for preclinical target validation. Here the authors extend the tTPD platform by developing NanoTACs that degrade NanoLuc tagged substrates and benchmark each tTPD system using an ...
Christoph Grohmann +22 more
doaj +4 more sources
Bright Red Bioluminescence from Semisynthetic NanoLuc (sNLuc)
Red-shifted bioluminescence is highly desirable for diagnostic and imaging applications. Herein, we report a semisynthetic NanoLuc (sNLuc) based on complementation of a split NLuc (LgBiT) with a synthetic peptide (SmBiT) functionalized with a fluorophore for BRET emission.
Russo, Francesco +2 more
openaire +3 more sources
An optimized luciferin formulation for NanoLuc-based in vivo bioluminescence imaging
Bioluminescence imaging (BLI) is widely used in preclinical biomedical research for noninvasive tracking of cell populations and biochemical events in vivo.
Chao Gao +9 more
doaj +3 more sources

